Hope is not a strategy. Science is.

We help biotech, pharma, medtech, and investment teams turn high-stakes clinical development decisions into regulator-, payer-, and investor-credible outcomes.

Talk to Us
Explore Services
DESIGN. EXECUTE. ACCELERATE.

Partner in Clinical Success

Manolo Beelke & Partners unites clinical strategy, trial execution, and leadership development. We guide pharma, biotech, and medtech companies from early planning to Phase I–IV operations. Let us help you de-risk and accelerate your clinical programs.

How we work
Meet Manolo

From strategy to controlled execution

One clinical architecture. One governance system. Local execution where it adds value.
OPERATING MODEL

Strong clinical development does not fail only in strategy. It fails when strategy is not translated into executable country, site, vendor, quality and evidence decisions. MB&P defines the clinical architecture. Verum provides the accountable execution spine. NECTAR adds qualified local CROs, specialist vendors, healthcare providers and clinical sites where regional depth improves regulatory fluency, patient access, recruitment realism and operational speed.

See How We Work
Faster FPI
+ 0 %
Lower screen-fail rate
- 0 %
On-time database lock
0 continents

Representative outcomes from selected programs and partner-network execution models. Results depend on indication, protocol complexity, geography and sponsor readiness.

LogoLogoLogoLogoLogoLogoLogoLogoLogoLogo

We align clinical plans with financing gates and run NECTAR-enabled execution so your readouts become underwriteable value-inflection points, credible to investors and payers.

CAPITAL. SCIENCE.

From Molecule to Investable Assets

  • Clear gates: endpoints and decision trees synced to funding rounds.
  • Diligence-ready: protocol/SAP, QA evidence, audit trail, risk register.
  • Interim readouts: timing, stats, and data packages built for IC memos.
Strategy. Execution. Leadership

Guiding Sponsors Through Every Clinical Phase

From indication fit to Phase I–IV operations, we combine protocol craftsmanship with NECTAR’s hub-and-spoke engine for fast start-up, disciplined delivery, and payer-credible data.

  • Design that works: inclusion, endpoints, stats payers trust.
  • Execution engine: rater QC, country/site selection, timeline control.
  • Recruitment reality: capacity & competition model—no wishful thinking.
Clinical trial phases from Phase 0 to Phase IV, showing objectives and typical timelines.

Results

Discover how our clients have achieved remarkable results with Manolo Beelke & Partners’ expert guidance.

“His contribution, commitment and professionalism … have been truly outstanding.”
Dr. Angelico Carta, MD
President & Co-Founder, Worldwide Clinical Trials
“Quickly earned the reputation of the ‘go to’ expert.”
Ram Yeleswarapu
Co-founder & past President/CEO, Navitas Life Sciences
“He was instrumental in completing the studies and FDA submission.”
Kohkan Shamsi, MD PhD
Principal & Co-Founder, RAD-MD
“A vital bridge between the country-based medical teams and head office… provided a solution-oriented approach, taking decisions in a very practical and objective manner.”
Jon Bastow
Healthcare specialist & strategic adviser , (working with WHO and partners)
“Extraordinary ability to incorporate medical expertise into clinical trial execution while providing state-of-the-art guidance.”
Marija Jovanovic
Associate Director, Project Management, Worldwide Clinical Trials
“Allowed [Worldwide Clinical Trials] to be awarded important projects due to his in-depth medical and scientific knowledge… a solution-oriented approach with practical, objective decisions.”
Tomislav Babic, MD PhD
Professor of Clinical Neurology; VP Neuroscience Franchise, Worldwide Clinical Trials
“Agility to work through conflicts with a solution-oriented approach… I have no hesitation in recommending Dr. Manolo Beelke.”
Kohkan Shamsi, MD PhD
Principal & Co-Founder, RAD-MD
“Excellent European medical direction and guidance… I would work with him again in a heartbeat.”
Arianna Pesci
Clinical Team Manager, Strategic Solutions (a division of PRA International), sponsor-dedicated to MSD Italy
“A highly respected medical expert with deep, practical operational insight—extremely rare and valuable.”
Steve Galen, PhD
Owner; Former Global Head, Clinical Division , Galen FP Solutions; Navitas Life Sciences.
“Whenever there were different opinions he provided a solution-oriented approach, taking decisions in a practical, objective manner.”
Jon Bastow
Healthcare specialist & strategic adviser , (working with WHO and partners)
“Valuable medical and strategic input into the design of clinical development programs… I strongly recommend Dr. Beelke without any hesitation.”
Dr. Angelico Carta, MD
President & Co-Founder, Worldwide Clinical Trials
“Brought the critical thinking and problem solving approach… [and] always challenged the status quo.”
Ram Yeleswarapu
Co-founder & past President/CEO, Navitas Life Sciences
“He is a monumental, multi-face leadership asset to any organization ready to see tangible results.”
Spencer M. Robinson, PhD
Founder, CASN
“His input was knowledgeable, focused and constructive.”
J. Fischer
CEO, Immungenetics AG
“Set a high bar of expectations… urge[d] creativity, efficiency… [and] adherence to timelines.”
Ram Yeleswarapu
Co-founder & past President/CEO, Navitas Life Sciences
“Dr. Manolo Beelke stands out … thanks to his originality of thinking and outstanding ability to give scientific contributions.”
Mauro Manconi, MD, PhD
Titular Professor; Head, University of Bern; Sleep & Epilepsy Center, Neurocenter of Southern Switzerland
“Ability to easily switch from tactical to strategic helped us immensely.”
Ram Yeleswarapu
Co-founder & past President/CEO, Navitas Life Sciences
“Dr. Beelke was extensively involved in the trial design… and the scientific writing of the paper.”
Prof. Raymond Hupperts
Neurologist & Head; Professor, Academic MS Center, Zuyderland Hospital; Maastricht University.
“Innovative in his outlook… [he] guided us to think differently… for Business Development or Delivery.”
Ram Yeleswarapu
Co-founder & past President/CEO, Navitas Life Sciences
“Combination of international expertise and business development/negotiations… provides sound, knowledgeable, realistic, timely advice.”
Spencer M. Robinson, PhD
Founder, CASN
“His knowledge and intelligence is of high academic level.”
Prof. Raymond Hupperts
Neurologist & Head; Professor, Academic MS Center, Zuyderland Hospital; Maastricht University.
“He stood out among the rest… a rare combination!” (medical/scientific depth + regulatory/operations know-how).
Ram Yeleswarapu
Co-founder & past President/CEO, Navitas Life Sciences
“Solution-oriented approach … decisions in a very practical and objective manner.”
Natasa Djurica, DVM, CCRA, MRQA
Senior Project Manager, Worldwide Clinical Trial
“His operational leadership and exceptionally scientific knowledge aligned perfectly with our needs.”
Spencer M. Robinson, PhD
Founder, CASN
“Roll up his sleeves and convert strategy to action.”
Ram Yeleswarapu
Co-founder & past President/CEO, Navitas Life Sciences
Science. System. Soul

We Develop People Who Deliver Outcomes

Skills, Habits and mindests, that turn cluinical strategy into execution – confident decisions, clean communciation, disciplined timelines.

Get In Touch

Reach out to discuss your clinical development needs.